MICHAEL D. LOBERG - 30 Jun 2022 Form 4 Insider Report for IGM Biosciences, Inc. (IGMS)

Role
Director
Signature
/s/ Misbah Tahir, by power of attorney
Issuer symbol
IGMS
Transactions as of
30 Jun 2022
Transactions value $
$0
Form type
4
Filing time
05 Jul 2022, 18:16:16 UTC
Previous filing
04 Apr 2022
Next filing
29 Sep 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IGMS Common Stock Gift $0 -533 -100% $0.00* 0 08 Apr 2022 Direct
transaction IGMS Common Stock Gift $0 +533 +2.45% $0.00 22.3K 08 Apr 2022 See footnote F1
transaction IGMS Common Stock Award $0 +533 $0.00 533 30 Jun 2022 Direct F2
holding IGMS Common Stock 43.1K 30 Jun 2022 See footnote F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares are held by the Revocable Deed of Trust of Michael D. Loberg (Michael and Melinda Loberg, Trustees), of which Reporting Person and his spouse serve as trustees.
F2 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The amount reflects payment of a quarterly retainer in common stock pursuant to the Issuer's Outside Director Compensation Policy.
F3 The shares are held by the Michael D. Loberg Qualified Annuity Interest Trust IX (Michael and Melinda Loberg, Trustees), of which Reporting Person and his spouse serve as trustees.